Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
permanent nerve damage; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of nerve damage in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 04-FEB-2019, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced nerve damage (Verbatim: permanent nerve damage). The outcome of the nerve damage was not resolved. It was unknown if the reporter considered the nerve damage to be related to Shingles vaccine. It was unknown if the company considered the nerve damage to be related to Shingles vaccine. Additional Information: GSK receipt date: 27-APR-2025 This case was reported by a patient via interactive digital media. The patient reported that they had received the round of medication on 04th February 2019 and when the first round did not work, they underwent a second round and unfortunately, this resulted in permanent nerve damage. The re[porter mentioned that by 2025, they were still suffering.